Dr. El Hadji Seydou MBAYE, PhD
Aristide Le Dantec Hospital, France
Dr. Anuj Tewari, PhD
Assistant Professor, Veterinary Microbiology
Govind Ballabh Pant University of Agriculture and Technology, India
Dr Kuldeep Dhama, MVSc, PhD
Principal Scientist, Pathology
Indian Veterinary Research Institute, India
Journal Impact Factor 1.67*
Submit manuscript at www.longdom.org/submissions/antivirals-antiretrovirals.html or send as an e-mail attachment to the Editorial Office at [email protected]
Table of Contents
About the Journal
NLM ID: 101526954
Index Copernicus Value: 108.6
The Journal of Antivirals & Antiretrovirals (JAA) paves the way to discovery and development of antiviral drugs, compounds, and clinical methods to prevent viral infections. Importantly, JAA provides the opportunity to inform researchers, clinicians, and others working in the field of antiviral drugs and therapies.
JAA is an internationally recognized journal for scientists involved in basic, applied, and clinical aspects of antiviral and antiretroviral research. It is known that many viruses emerge and re-emerge threatening both animal and human populations. Zoonotic viruses can cause extensive morbidity and mortality; however, preventive vaccines that provide protection are available for only a limited number of viruses.
The primary current therapeutic approach against viral diseases is to target viral components that are essential for replication. There are a number of disadvantages targeting viral components including the limited number of druggable viral targets because viruses have a small genome, as well as the rapid development of drug resistance. New drug therapies combine antivirals to increase efficacy and to avoid the development of drug resistant strains. These strategies are effective for viruses such as HIV, but clearly there is a need to expand our drug arsenal to address the wide diversity of viruses. This pathway relies on alternative strategies for drug discovery, such as examining the virus-host interface.
Journal of Antivirals & Antiretrovirals is using Editorial Manager System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems used by most of the best open access journals. Review processing is performed by the editorial board members of journal or outside experts; at least two independent reviewers approval followed by editor's approval is required for acceptance of any citable manuscript.
Send your manuscript at www.longdom.org/submissions/antivirals-antiretrovirals.html or as an e-mail attachment to our Editorial Office at [email protected]clinicalsci.com